Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033
Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033(摘要待生成)
Earnings Snapshot: Pfizer names Cecile Guegan CFO, raises FY26 outlook after Q3 beat
Earnings Snapshot: Pfizer names Cecile Guegan CFO, raises FY26 outlook after Q3 beat(摘要待生成)
Earnings from AMD and Pfizer plus labor market data: What to Watch - Yahoo Finance
Earnings from AMD and Pfizer plus labor market data: What to Watch - Yahoo Finance(摘要待生成)
PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance - Zacks Investment Research
PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance - Zacks Investment Research(摘要待生成)
Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?
Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?(摘要待生成)
Pfizer Stock Down 6% Post Q3 Earnings: Time to Buy, Hold or Exit? - Yahoo Finance
Pfizer Stock Down 6% Post Q3 Earnings: Time to Buy, Hold or Exit? - Yahoo Finance(摘要待生成)
Pfizer (PFE) Q3 Earnings Rebuild Confidence As New Drugs Gain Ground - Yahoo Finance
Pfizer (PFE) Q3 Earnings Rebuild Confidence As New Drugs Gain Ground - Yahoo Finance(摘要待生成)
Pfizer Q3 Earnings Call Highlights - Yahoo Finance
Pfizer Q3 Earnings Call Highlights - Yahoo Finance(摘要待生成)
Pfizer Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Pfizer Inc. Q3 2026 Earnings Call Summary - Yahoo Finance(摘要待生成)
Pfizer (PFE) Q3 2026 Earnings Call Transcript
Pfizer (PFE) Q3 2026 Earnings Call Transcript(摘要待生成)
Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings - Benzinga
Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings Benzinga
Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction
Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction(摘要待生成)
Pfizer earnings take a tumble as revenue slips in third quarter - Yahoo Finance
Pfizer earnings take a tumble as revenue slips in third quarter - Yahoo Finance(摘要待生成)
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Pfizer reported third-quarter revenue of $16.6 billion, above analyst expectations of $15.9 billion. [[fact:fact-9srxk423d]] Adjusted earnings were 87 cents per share, exceeding Wall Street estimates of 73 cents. [[fact:fact-xod1cdw4f]] The company raised its full-year adjusted earnings guidance to $2.95–$3.05 per share from $2.80–$3. [[fact:fact-96osk75n0]] Revenue from launched and acquired products rose 32% in the quarter. [[fact:fact-4ob8085ur]]
Pfizer increases annual profit forecast amid solid demand for blood thinner drug - Yahoo Finance
Pfizer increases annual profit forecast amid solid demand for blood thinner drug - Yahoo Finance(摘要待生成)
Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates
Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates(摘要待生成)
Pfizer: Q3 Earnings Snapshot - Yahoo Finance
Pfizer: Q3 Earnings Snapshot - Yahoo Finance(摘要待生成)
Midday Need to Know: Trump signals end to Israel aid, Pfizer raises 2026 outlook & more
Midday Need to Know: Trump signals end to Israel aid, Pfizer raises 2026 outlook & more(摘要待生成)
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? - Yahoo Finance
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? - Yahoo Finance(摘要待生成)
Axios: Blackstone to fund Pfizer monthly GLP-1 program
On Nov. 11, Pfizer and Blackstone announced up to $1.5 billion in funding through 2028 for berobenatide, an investigational monthly GLP-1 for chronic weight management. Pfizer said it plans 10 ongoing or planned Phase 3 trials for the drug in 2026.
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more - CNBC
Apple shares were down nearly 4% in premarket trading. [[fact-a1otztlqb]] Palantir shares were down nearly 8%. [[fact-pyqk8qbd9]] Zebra Technologies fell over 6%. [[fact-t51b386ws]] Zebra's full-year free cash flow guidance was at least $1 billion, marginally below the $1.02 billion estimate. [[fact-cu3bowrkt]]